Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / HUGE - FSD Pharma rockets on FDA approval of FSD-201 trial to treat COVID-19 patients


HUGE - FSD Pharma rockets on FDA approval of FSD-201 trial to treat COVID-19 patients

  • FSD Pharma (NASDAQ:HUGE) is up 116% premarket on the heels of announcement that the FDA has permitted company to submit an Investigational New Drug (IND) Application for the use of FSD-201 (ultramicronized palmitoylethanolamide, or ultramicronized PEA) to treat COVID-19.
  • More news on: FSD Pharma Inc., Healthcare stocks news, Stocks on the move,
  • Read more ...
Stock Information

Company Name: FSD Pharma Inc.
Stock Symbol: HUGE
Market: NASDAQ
Website: fsdpharma.com

Menu

HUGE HUGE Quote HUGE Short HUGE News HUGE Articles HUGE Message Board
Get HUGE Alerts

News, Short Squeeze, Breakout and More Instantly...